Genetic susceptibility to dental implant failure: A critical review

International Journal of Oral and Maxillofacial Implants

Volumn 23, Issue 3, 2008, Pages 409-416

  Alvim Pereira, Fabino ^a,b   Montes, Claudia C ^a   Mira, Marcelo T ^a   Trevilatto, Paula C ^a  

^a PONTIFICAL CATHOLIC UNIVERSITY OF PARANÁ   (Brazil)

^b Latin American Institute of Dental Research and Education ILAPEO   (Brazil)

Author keywords

Dental implant; Genetic approaches; Implant failure; Osseointegration; Polymorphisms

Indexed keywords

INTERLEUKIN DERIVATIVE; MATRIX METALLOPROTEINASE; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BONE REGENERATION; DENTAL SURGERY; GENETIC POLYMORPHISM; GENETICS; HUMAN; MULTIFACTORIAL INHERITANCE; TOOTH IMPLANTATION;

DENTAL IMPLANTATION, ENDOSSEOUS; DENTAL IMPLANTS; DENTAL RESTORATION FAILURE; HUMANS; INTERLEUKINS; MATRIX METALLOPROTEINASES; MULTIFACTORIAL INHERITANCE; OSSEOINTEGRATION; POLYMORPHISM, GENETIC; TUMOR NECROSIS FACTOR-ALPHA;

EID: 47249134612     PISSN: 08822786     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (101)

1. Albrektsson T, Brånemark P-I, Hansson HA, Lindstrom J. Osseointegrated titanium implants. Requirements for ensuring a long-lasting, direct bone-to-implant anchorage in man. Acta Orthop Scand 1981;52:155-170.
2. Roberts WE, Simmons KE, Garetto LP, DeCastro RA. Bone physiology and metabolism in dental implantology: Risk factors for osteoporosis and other metabolic bone diseases. Implant Dent 1992;1:11-21.
3. Danesh-Meyer MJ. Dental Implants. Part I: Biological basis, implant types, and the peri-implant sulcus. J N Z Soc Periodontal 1994 May;(77):15-22.
4. Kronstrom M, Svenson B, Hellman M, Persson GR. Early implant failures in patients treated with Branemark System titanium dental implants: A retrospective study. Int J Oral Maxillofac Implants 2001;16:201-207.
5. Davarpanah M, Martinez H, Etienne D, et al. A prospective multicenter evaluation of 1,583 3i implants: 1 - to 5-year data. Int J Oral Maxillofac Implants 2002;17:820-828.
6. Fugazzotto PA. Success and failure rates of osseointegrated implants in function in regenerated bone for 72 to 133 months. Int J Oral Maxillofac Implants 2005;20:77-83.
7. Davies JE. Understanding peri-implant endosseous healing. J Dent Educ 2003;67:932-949.
8. Esposito M, Worthington HV, Coulthard P. Interventions for replacing missing teeth:Treatment of perimplantitis. Cochrane Database Syst Rev 2004:CD004970.
9. Graziani F, Donos N, Needleman I, Gabriele M, Tonetti M. Comparison of implant survival following sinus floor augmentation procedures with implants placed in pristine posterior maxillary bone: A systematic review. Clin Oral Implants Res 2004;15:677-682.
10. Esposito M, Hirsch J, Lekholm Thomsen P. Differential diagnosis and treatment strategies for biologic complications and failing oral implants: A review of the literature. Int J Oral Maxillofac Implants 1999;14:473-490.
11. Ganeles J, Wismeijer D. Early and immediately restored and loaded dental implants for single-tooth and partial-arch applications. Int J Oral Maxillofac Implants 2004;19(suppl):92-102.
12. Moy PK, Medina D, Shetty V. Aghaloo TL. Dental implant failure rates and associated risk factors. Int J Oral Maxillofac Implants 2005;20:569-577.
13. Quirynen M, Teughels W. Microbiologically compromised patients and impact on oral implants. Periodontol 2000 2003;33:119-128.
14. Weyant RJ, Burt BA. An assessment of survival rates and within-patient clustering of failures for endosseous oral implants. J Dent Res 1993;72:2-8.
15. Degidi M, Piattelli A. 7-year follow-up of 93 immediately loaded titanium dental implants. J Oral lmplantol 2005;31:25-31.
16. Stanford CM. Bone quantity and quality: Are they relevant predictors of implant outcomes? Int J Prosthodont 2003;16(suppl):43-45.
17. Rosenberg ES, Cho SC, Elian N, Jalbout ZN, Froum S, Evian Cl. A comparison of characteristics of implant failure and survival in periodontally compromised and periodontally healthy patients: A clinical report. Int J Oral Maxillofac Implants 2004;19:873-879.
18. Gruica B, Wang HY, Lang NP, Buser D. Impact of IL-1 genotype and smoking status on the prognosis of osseointegrated implants. Clin Oral Implants Res 2004;15:393-400.
19. van Steenberghe D, Quirynen M. The implant/tissue interface in a clinical perspective [in German]. Parodontol 1990;1:343-350.
20. Kuttenberger JJ, Hardt N, RutzT, Pfyffer GE. Bone collected with a bone collector during dental implant surgery [in German]. Mund Kiefer Gesichtschir 2005;9:18-23.
21. Misch CE, Wang HL, Misch CM, Sharawy M, Lemons J, Judy KW. Rationale for the application of immediate load in implant dentistry: Part II. Implant Dent 2004;13:310-321.
22. Deas DE, Mikotowicz JJ, Mackey SA, Moritz AJ. Implant failure with spontaneous rapid exfoliation:Case reports. Implant Dent 2002;11:235-242.
23. Tonetti MS. Determination of the success and failure of root-form osseointegrated dental implants. Adv Dent Res 1999;13:173-180.
24. Hutton JE, Heath MR, Chai JY, et al. Factors related to success and failure rates at 3-year follow-up in a multicenter study of overdentures supported by Brånemark implants. Int J Oral Maxillofac Implants 1995;10:33-42.
25. Esposito M, Hirsch JM, Lekholm Thomsen P. Biological factors contributing to failures of osseointegrated oral implants. (II). Etlopathogenesis. Eur J Oral Sci 1998;106:721-764.
26. Schutte BC, Murray JC. The many faces and factors of orofacial clefts. Hum Mol Genet 1999;8:1853-1859.
27. Muhle R, Trentacoste SV, Rapin I. The genetics of autism. Pediatrics 2004;113:e472-486.
28. Weeks DE, Lange K. A multilocus extension of the affected-pedigree-member method of linkage analysis. Am J Hum Genet 1992;50:859-868.
29. Borecki IB, Suarez BK. Linkage and association: Basic concepts. Adv Genet 2001;42:45-66.
30. Botstein D, Risch N. Discovering genotypes underlying human phenotypes: past successes for mendelian disease, future approaches for complex disease. Nat Genet 2003;33(suppl): 228-237.
31. Risch N, Merikangas K. The future of genetic studies of complex human diseases. Science 1996;273:1516-1517.
32. Lander E, Kruglyak L. Genetic dissection of complex traits: Guidelines for interpreting and reporting linkage results. Nat Genet 1995;11:241-247.
33. Gordon D, Finch SJ. Factors affecting statistical power in the detection of genetic association. J Clin Invest 2005;115:1408-1418.
34. Lea RA, Nyholt DR, Curtain RP, et al. A genome-wide scan provides evidence for loci influencing a severe heritable form of common migraine. Neurogenetics 2005;6:67-72.
35. Risch N, Spiker D, Lotspeich L, et al. A genomic screen of autism: Evidence for a multilocus etiology. Am J Hum Genet 1999;65:493-507.
36. Lander ES, Schork NJ. Genetic dissection of complex traits. Science 1994;265:2037-2048.
37. Lohmueller KE, Pearce CL, Pike M, Lander ES, Hirschhorn JN. Meta-analysis of genetic association studies supports a contribution of common variants to susceptibility to common disease. Nat Genet 2003;33:177-182.
38. Devlin B, Roeder K, Bacanu SA. Unbiased methods for population-based association studies. Genet Epidemiol 2001;21:273-284.
39. Mayeux R. Mapping the new frontier: Complex genetic disorders. J Clin Invest 2005;115:1404-1407.
40. Bosse Y, Chagnon YC, Despres JP, et al. Compendium of genome-wide scans of lipid-related phenotypes: Adding a new genome-wide search of apolipoprotein levels. J Lipid Res 2004;45:2174-2184.
41. Mira MT, Alcais A, Nguyen VT, et al. Susceptibility to leprosy is associated with PARK2 and PACRG. Nature 2004;427:636-640.
42. Chiba-Falek O, Nussbaum RL. Effect of allelic variation at the NACP-Rep1 repeat upstream of the alpha-synuclein gene (SNCA) on transcription in a cell culture luciferase reporter system. Hum Mol Genet 2001;10:3101-3109.
43. Min-Oo G, Gros P. Erythrocyte variants and the nature of their malaria protective effect. Cell Microbiol 2005;7:753-763.
44. Lao JI, Montoriol C, Morer I, Beyer K. Genetic contribution to aging: deleterious and helpful genes define life expectancy. Ann N Y Acad Sci 2005;1057:50-63.
45. Knight JC. Regulatory polymorphisms underlying complex disease traits. J Mol Med 2005;83:97-109.
46. Matheson MC, Ellis JA, Raven J, Walters EH, Abramson MJ. Association of IL8, CXCR2 and TNF-alpha polymorphisms and airway disease. J Hum Genet 2006;51:196-203.
47. Nares S. The genetic relationship to periodontal disease. Periodontol 2000 2003;32:36-49.
48. Campos MI, dos Santos MC, Trevilatto PC, Scarel-Caminaga RM, Bezerra FJ, Line SR. Early failure of dental implants and TNF-alpha (G-308A) gene polymorphism. Implant Dent 2004;13:95-101.
49. Shimpuku H, Nosaka Y, Kawamura T, Tachi Y, Shinohara M, Ohura K. Genetic polymorphisms of the interleukin-1 gene and early marginal bone loss around endosseous dental implants. Clin Oral Implants Res 2003;14:423-429.
50. Santos MC, Campos MI, Souza AP, Trevilatto PC, Line SR. Analysis of MMP-1 and MMP-9 promoter polymorphisms in early osseointegrated implant failure. Int J Oral Maxillofac Implants 2004;19:38-43.
51. Santos MC, Campos MI, Souza AP, Scarel-Caminaga RM, Mazzonetto R, Line SR. Analysis of the transforming growth factorbeta 1 gene promoter polymorphisms in early osseointegrated implant failure. Implant Dent 2004,13:262-269.
52. Bathon JM, Proud D, Krackow K, Wigley FM. Preincubation of human synovial cells with IL-1 modulates prostaglandin E2 release in response to bradykinin. J Immunol 1989;143:579-586.
53. Shanbhag AS, Jacobs JJ, Black J, Galante JO, Glant TT. Human monocyte response to particulate biomaterials generated in vivo and in vitro. J Orthop Res 1995;13:792-801.
54. Kornman KS, Crane A, Wang HY, et al. The interleukin-1 geno-type as a severity factor in adult periodontal disease. J Clin Periodontol 1997;24:72-77.
55. Perala DG, Chapman RJ, Gelfand JA, Callahan MV, Adams DF, Lie T. Relative production of IL-1 beta and TNF alpha by mononuclear cells after exposure to dental implants. J Periodontol 1992;63:426-430.
56. Rogers MA, Figliomeni L, Baluchova K, et al. Do interleukin-1 polymorphisms predict the development of periodontitis or the success of dental implants? J Periodontal Res 2002;37:37-41.
57. Campos MI, Santos MC, Trevilatto PC, Scarel-Caminaga RM, Bezerra FJ, Line SR. Evaluation of the relationship between interleukin-1 gene cluster polymorphisms and early implant failure in non-smoking patients. Clin Oral Implants Res 2005;16:194-201.
58. Wilson TG Jr, Nunn M. The relationship between the interleukin-1 periodontal genotype and implant loss. Initial data. J Periodontol 1999;70:724-729.
59. Jansson H, Hamberg K, De Bruyn H, Bratthall G. Clinical consequences of IL-1 genotype on early implant failures in patients under periodontal maintenance. Clin Implant Dent Relat Res 2005;7:51-59.
60. Feloutzis A, Lang NP, Tonetti MS, et al. IL-1 gene polymorphism and smoking as risk factors for peri-implant bone loss in a well-maintained population. Clin Oral Implants Res 2003;14:10-17.
61. Tew JG, Kosco MH, Szakal AK. The alternative antigen pathway. Immunol Today 1989;10:229-232.
62. Wilson AD, Shooshstari M, Finerty S, Watkins P, Morgan AJ. Virus-specific cytotoxic T cell responses are associated with immunity of the cottontop tamarin to Epstein-Barr virus (EBV). Clin Exp Immunol 1996;103:199-205.
63. Parkes M, Satsangi J, Jewell D. Contribution of the IL-2 and IL-10 genes to inflammatory bowel disease (IBD) susceptibility. Clin Exp Immunol 1998;113:28-32.
64. Ries WL, Seeds MC, Key LL Interleukin-2 stimulates osteoclastic activity: Increased acid production and radioactive calcium release. J Periodontal Res 1989;24:242-246.
65. Campos MI, Godoy dos Santos MC, Trevilatto PC, Scarel-Caminaga RM, Bezerra FJ, Line SR. Interleukin-2 and interleukin-6 gene promoter polymorphisms, and early failure of dental implants. Implant Dent 2005;14:391-396.
66. Shimpuku H, Nosaka Y, Kawamura T, Tachi Y, Shinohara M, Ohura K. Bone morphogenetic protein-4 gene polymorphism and early marginal bone loss around endosseous implants. Int J Oral Maxillofac Implants 2003;18:500-504.
67. Nosaka Y, Tachi Y, Shimpuku H, Kawamura T, Ohura K. Association of calcitonin receptor gene polymorphism with early marginal bone loss around endosseous implants. Int J Oral Maxillofac Implants 2002;17:38-43.
68. Lotz M, Jirik F, Kabouridis P, et al. B cell stimulating factor 2/interleukin 6 is a costimulant for human thymocytes and T lymphocytes. J Exp Med 1988;167:1253-1258.
69. Revel M. Host defense against infections and inflammations: Role of the multifunctional IL-6/IFN-beta 2 cytokine. Experiential 989:45:549-557.
70. Ishimi Y, Miyaura C, Jin CH, et al. IL-6 is produced by osteoblasts and induces bone resorption. J Immunol 1990;145:3297-3303.
71. Scarel-Caminaga RM, Trevilatto PC, Souza AR Brito RB, Line SR. Investigation of an IL-2 polymorphism in patients with different levels of chronic periodontitis. J Clin Periodontol 2002;29:587-591.
72. Trevilatto PC, Scarel-Caminaga RM, de Brito RB Jr, de Souza AP, Line SR. Polymorphism at position -174 of IL-6 gene is associated with susceptibility to chronic periodontitis in a Caucasian Brazilian population. J Clin Periodontol 2003;30:438-442.
73. Beutler B, Cerami A. The biology of cachectin/TNF;209;A primary mediator of the host response. Annu Rev Immunol 1989;7:625-655.
74. Vassalli P. The pathophysiology of tumor necrosis factors. Annu Rev Immunol 1992;10:411-452.
75. Bertolini DR, Nedwin GE, Bringman TS, Smith DD, Mundy GR. Stimulation of bone resorption and inhibition of bone formation in vitro by human tumour necrosis factors. Nature 1986;319:516-518.
76. Johnson RA, Boyce BF, Mundy GR, Roodman GD. Tumors producing human tumor necrosis factor induced hypercalcemia and osteoclastic bone resorption In nude mice. Endocrinology 1989;124:1424-1427.
77. Kim SJ, Glick A, Sporn MB, Roberts AB. Characterization of the promoter region of the human transforming growth factor-beta 1 gene. J Biol Chem 1989;264:402-408.
78. Birkedal-Hansen H. Role of matrix metalloproteinases in human periodontal diseases. J Periodontol 1993;64:474-484.
79. Oum'hamed Z, Garnotel R, Josset Y, Trenteseaux C, Laurent-Maquin D. Matrix metalloproteinases MMP-2,-9 and tissue inhibitors TIMP-1, -2 expression and secretion by primary human osteoblast cells in response to titanium, zirconia, and alumina ceramics. J Biomed Mater Res A 2004;68:114-122.
80. Takei, I, Takagi M, Santavirta S, et al. Messenger ribonucleic acid expression of 16 matrix metalloproteinases in bone-implant interface tissues of loose artificial hip joints. J Biomed Mater Res 2000;52:613-620.
81. Dominici R, Cattaneo M, Malferrari G, et al. Cloning and functional analysis of the allelic polymorphism in the transcription regulatory region of interleukin-1 alpha. Immunogenetics 2002;54:82-86.
82. Cox A, Camp NJ, Nicklin MJ, di Giovine FS, Duff GW. An analysis of linkage disequilibrium in the interleukin-1 gene cluster, using a novel grouping method for multiallelic markers. Am J Hum Genet 1998;62:1180-1188.
83. Pociot F, Molvig J, Wogensen L, Worsaae H, Nerup J. A Taqi polymorphism in the human interleukin-1 beta (IL-1 beta) gene correlates with IL-1 beta secretion in vitro. Eur J Clin Invest 1992;22:396-402.
84. Hu S, Song QB, Yao PF, et al. No relationship between IL-1B gene polymorphism and gastric add secretion in younger healthy volunteers, World J Gastroenterol 2005;11:6549-6553.
85. Hoffmann SC, Stanley EM, Darrin Cox E, et al. Association of cytokine polymorphic inheritance and in vitro cytokine production in anti-CD3/CD28- stimulated peripheral blood lymphocytes. Transplantation 2001;72:1444-1450.
86. Fishman D, Faulds G, Jeffery R, et al. The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. J Clin Invest 1998;102:1369-1376.
87. Hajeer AH, Hutchinson IV. Influence of TNFalpha gene polymorphisms on TNFalpha production and disease. Hum Immunol 2001;62:1191-1199.
88. Rutter JL, Mitchell TI, Buttice G, et al. A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter creates an Ets binding site and augments transcription. Cancer Res 1998;58:5321-5325.
89. Zhang B, Ye S, Herrmann SM, et al. Functional polymorphism In the regulatory region of gelatinase B gene in relation to severity of coronary atherosclerosis. Circulation 1999;99:1788-1794.
90. Mangino M, Torrente I, De Luca A, Sanchez O, Dallapiccola B, Novelli G. A single-nucleotide polymorphism in the human bone morphogenetic protein-4 (BMP 4) gene. J Hum Genet 1999;44:76-77.
91. Nakamura M, Zhang ZQ, Shan L, et al. Allelic variants of human calcitonin receptor in the Japanese population, Hum Genet 1997;99:38-41.
92. Baltimore D. Our genome unveiled. Nature 2001;409:814-816.
93. Sachidanandam R, Weissman D, Schmidt SC, et al. A map of human genome sequence variation containing 1.42 million single nucleotide polymorphisms. Nature 2001;409:928-933.
94. Venter JC, Adams MD, Myers EW, et al. The sequence of the human genome. Science 2001;291:1304-1351.
95. NCBI, release. NCBI dbSNP Build 126. Available at: http://www.ncbi.nlm. nih.gov/projects/SNP/snp_summary.cgi.
96. Thomas DC, Halle RW, Duggan D. Recent developments in genome-wide association scans: A workshop summary and review. Am J Hum Genet 2005;77:337-345,
97. Maraganore DM, de Andrade M, Lesnlck TG, et al. High-resolution whole-genome association study of Parkinson disease. Am J Hum Genet 2005;77:685-693.
98. Hirschhorn JN, Daly MJ. Genome-wide association studies for common diseases and complex traits. Nat Rev Genet 2005;6:95-108.
99. Detera-Wadleigh SD, McMahon FJ. Genetic association studies in mood disorders: Issues and promise. Int Rev Psychiatry 2004;16:301-310.
100. Marchinl J, Cardon LR, Phillips MS, Donnelly P. The effects of human population structure on large genetic association studies. Nat Genet 2004;36:512-517.
101. Neale BM, Sham PC. The future of association studles:Gene-based analysis and replication. Am J Hum Genet 2004;75:353-362.